Joinn Laboratories (06127) appoints Luo Xi and Gu Jingliang as executive directors.
Chao Yan New Drug (06127) announced the appointment of Ms. Luo Xi and Mr. Gu Jingliang as executive directors; ...
Joinn Laboratories (06127) announces the appointment of the following: (i) Ms. Luo Xi and Mr. Gu Jingliang as executive directors; (ii) Mr. Yang Fuquan, Mr. Yang Changyun, and Mr. Ying Fangtian as independent non-executive directors, effective from the conclusion of the extraordinary general meeting. In addition, from the date of the conclusion of the extraordinary general meeting, (i) Ms. Sun Yunxia will be appointed as a member of the company's remuneration and assessment committee and strategic committee; (ii) Ms. Luo Xi will be appointed as a member of the strategic committee; (iii) Mr. Yang Fuquan will be appointed as the chairman of the company's nomination committee and a member of the audit committee; (iv) Mr. Yang Changyun will be appointed as the chairman of the audit committee and a member of the remuneration and assessment committee; and (v) Mr. Ying Fangtian will be appointed as the chairman of the remuneration and assessment committee and a member of the strategic committee and nomination committee.
Related Articles

RECBIO-B(02179): Electing Xu Haoyu as Chairman.

HANS GP Holdings (00554) issued a total of 249 million share options.

XINYI ENERGY (03868) plans to acquire all the equity of Jinzhai Xinyi Wind Power for 62 million yuan.
RECBIO-B(02179): Electing Xu Haoyu as Chairman.

HANS GP Holdings (00554) issued a total of 249 million share options.

XINYI ENERGY (03868) plans to acquire all the equity of Jinzhai Xinyi Wind Power for 62 million yuan.

RECOMMEND





